Newcourt Acquisition Corp (NCAC)
Price:
4.79 USD
( - -1.10 USD)
Your position:
0 USD
ACTION PANEL
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Centurion Acquisition Corp.
VALUE SCORE:
5
2nd position
Melar Acquisition Corp. I
VALUE SCORE:
11
The best
M3-Brigade Acquisition V Corp. Units
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Newcourt Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Oakland, California.
NEWS

Why Is Newcourt Acquisition (NCAC) Stock Down 16% Today?
investorplace.com
2024-01-23 08:51:06Newcourt Acquisition (NASDAQ: NCAC ) stock is falling on Tuesday as the special purpose acquisition company (SPAC) provides investors with an update on its business combination plans. According to a press release, the business combination conditions between it and Pubco haven't been satisfied yet.

Newcourt Acquisition Corp Announces Continuation of Business Combination Close Process
globenewswire.com
2024-01-22 23:39:00NEW YORK, NY, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Newcourt Acquisition Corp (“Newcourt”) (NASDAQ: NCAC) announced today that the conditions to closing the business combination (the “Business Combination”) pursuant to the Amended and Restated Business Combination Agreement, dated July 31, 2023 (as amended, supplemented, or otherwise modified from time to time, the “Amended and Restated Business Combination Agreement”), by and among Newcourt, Newcourt SPAC Sponsor LLC, Psyence Group Inc. (CSE: PSYG) (“Psyence”), Psyence Biomedical Ltd., a corporation organized under the laws of Ontario, Canada (“Pubco”), Psyence (Cayman) Merger Sub, Psyence Biomed Corp., and Psyence Biomed II Corp. have not yet been satisfied and the business combination has not closed. The parties are working together to expeditiously satisfy such closing conditions, including obtaining the approval of Nasdaq to list Pubco's ordinary shares following the closing of the business combination. On January 22, 2024, Newcourt's shareholders approved to extend the date by which Newcourt must consummate its initial business combination from January 22, 2024 to February 22, 2024. There can be no assurance that the business combination will be consummated by February 22, 2024.

Tinubu has capacity to transform tourism sector – Runsewe
warritatafo.com
2023-06-23 06:53:54Otunba Olusegun Runsewe, Director-General National Council for Arts and Culture (NCAC), says President Bola Tinubu has the capacity to take the nation’s tourism sector to [...] The post Tinubu has capacity to transform tourism sector – Runsewe appeared first on Warri Tatafo...
No data to display

Why Is Newcourt Acquisition (NCAC) Stock Down 16% Today?
investorplace.com
2024-01-23 08:51:06Newcourt Acquisition (NASDAQ: NCAC ) stock is falling on Tuesday as the special purpose acquisition company (SPAC) provides investors with an update on its business combination plans. According to a press release, the business combination conditions between it and Pubco haven't been satisfied yet.

Newcourt Acquisition Corp Announces Continuation of Business Combination Close Process
globenewswire.com
2024-01-22 23:39:00NEW YORK, NY, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Newcourt Acquisition Corp (“Newcourt”) (NASDAQ: NCAC) announced today that the conditions to closing the business combination (the “Business Combination”) pursuant to the Amended and Restated Business Combination Agreement, dated July 31, 2023 (as amended, supplemented, or otherwise modified from time to time, the “Amended and Restated Business Combination Agreement”), by and among Newcourt, Newcourt SPAC Sponsor LLC, Psyence Group Inc. (CSE: PSYG) (“Psyence”), Psyence Biomedical Ltd., a corporation organized under the laws of Ontario, Canada (“Pubco”), Psyence (Cayman) Merger Sub, Psyence Biomed Corp., and Psyence Biomed II Corp. have not yet been satisfied and the business combination has not closed. The parties are working together to expeditiously satisfy such closing conditions, including obtaining the approval of Nasdaq to list Pubco's ordinary shares following the closing of the business combination. On January 22, 2024, Newcourt's shareholders approved to extend the date by which Newcourt must consummate its initial business combination from January 22, 2024 to February 22, 2024. There can be no assurance that the business combination will be consummated by February 22, 2024.

Tinubu has capacity to transform tourism sector – Runsewe
warritatafo.com
2023-06-23 06:53:54Otunba Olusegun Runsewe, Director-General National Council for Arts and Culture (NCAC), says President Bola Tinubu has the capacity to take the nation’s tourism sector to [...] The post Tinubu has capacity to transform tourism sector – Runsewe appeared first on Warri Tatafo...